Benign Thyroid Diseases: Are There Gender-Specific Differences for Diagnosis and Treatment of Nontoxic Thyroid Nodules? Results from a 4-Year Retrospective Analysis of an Endocrine Tumor Board.

Benign thyroid disease Bethesda Fine needle biopsy Gender

Journal

Visceral medicine
ISSN: 2297-4725
Titre abrégé: Visc Med
Pays: Switzerland
ID NLM: 101681546

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 27 11 2019
accepted: 17 12 2019
entrez: 29 2 2020
pubmed: 29 2 2020
medline: 29 2 2020
Statut: ppublish

Résumé

Benign nodular goiters are endemic in Germany and diagnostic thyroidectomy is one of the most frequent surgical procedures. Less than 10% result in a malignant finding which is a poor ratio in comparison to other European countries. There is a female preponderance in almost all thyroid pathologies according to the current literature but not much is known concerning gender-specific differences in thyroid nodules. We aimed at finding gender-specific differences in diagnosis and treatment of nontoxic thyroid nodules and focused on preoperative workup as well as cytological and histological findings of patients with solitary and multinodular nontoxic goiters. We retrospectively analyzed 392 cases out of 693 thyroid cases managed interdisciplinarily by the endocrine board of a university center between January 2015 and December 2018 (4 years). The combination of fine needle biopsy and interdisciplinary case discussion resulted in a rate of malignancy of 28.9% in patients undergoing surgery for solitary and multinodular nontoxic goiter. Although there was no significant gender-specific difference in the distributions and malignancy rates of Bethesda categories, male patients had a significantly higher malignancy rate of 40% in our collective ( Surgical treatment for male patients with suspicious hypofunctioning thyroid nodules should be favored. However, well-designed prospective studies are required to investigate gender-specific recommendations for the treatment of benign thyroid diseases in the future.

Identifiants

pubmed: 32110654
doi: 10.1159/000505499
pii: vis-0036-0028
pmc: PMC7036535
doi:

Types de publication

Journal Article

Langues

eng

Pagination

28-33

Informations de copyright

Copyright © 2020 by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors declare to have no conflicts of interest and no nonfinancial relationships that may have influenced the writing of the manuscript.

Références

PLoS One. 2018 Feb 1;13(2):e0190738
pubmed: 29390008
J Clin Endocrinol Metab. 2000 Mar;85(3):1038-42
pubmed: 10720036
Thyroid. 2007 Dec;17(12):1229-34
pubmed: 17949264
Endocrine. 2013 Oct;44(2):448-53
pubmed: 23397523
Endocr Pract. 2016 Nov;22(11):1336-1342
pubmed: 27540885
Clin Endocrinol (Oxf). 2015 Nov;83(5):717-25
pubmed: 25845636
J Clin Med. 2019 Apr 08;8(4):
pubmed: 30965665
Cureus. 2018 Mar 19;10(3):e2348
pubmed: 29796360
Thyroid. 2017 Nov;27(11):1341-1346
pubmed: 29091573
Thyroid. 2016 Oct;26(10):1343-1421
pubmed: 27521067
Dtsch Arztebl Int. 2018 Jan 8;115(1-02):1-7
pubmed: 29345225
J Clin Endocrinol Metab. 2013 Mar;98(3):1147-53
pubmed: 23345094
J Clin Transl Endocrinol. 2018 Oct 25;14:39-45
pubmed: 30416974
Eur Thyroid J. 2018 Aug;7(4):167-186
pubmed: 30283735

Auteurs

Jasmin Mettler (J)

Department of Nuclear Medicine, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany.

Stella Armefti (S)

Department of General, Visceral, Cancer and Transplantation Surgery, University of Cologne, Cologne, Germany.

Matthias Schmidt (M)

Department of Nuclear Medicine, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany.

Michael Faust (M)

Department of Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany.

Marianne Engels (M)

Department of Pathology, University of Cologne, Cologne, Germany.

Costanza Chiapponi (C)

Department of General, Visceral, Cancer and Transplantation Surgery, University of Cologne, Cologne, Germany.

Classifications MeSH